Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Revenue

Crescita Therapeutics had revenue of 6.23 million CAD in the quarter ending June 30, 2025, with 52.47% growth. This brings the company's revenue in the last twelve months to 20.27 million, up 20.33% year-over-year. In the year 2024, Crescita Therapeutics had annual revenue of 19.58 million with 11.75% growth.

• Revenue (ttm): 20.27M
• Revenue Growth: +20.33%
• P/S Ratio: 0.42
• Revenue / Employee: n/a
• Employees: 62
• Market Cap: 8.58M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.58M	2.06M	11.75%
Dec 31, 2023	17.52M	-6.00M	-25.52%
Dec 31, 2022	23.53M	6.76M	40.29%
Dec 31, 2021	16.77M	1.13M	7.22%
Dec 31, 2020	15.64M	-6.70M	-29.98%